SCIENTIST AND POSTDOCTORAL VACANCIES
IN CANCER RESEARCH
MARIE CURIE CENTER OF EXCELLENCE
VTT TECHNICAL RESEARCH CTR
AND THE UNIV. TURKU, FINLAND
VTT-Medical Biotechnology is a new research unit of the VTT Technical Research Centre of
Finland launched in 2002 in collaboration with the University of Turku and the City of Turku
located in South-western Finland. The unit has a unique infrastructure for high-throughput
cancer research, including multiple array technologies, cell-based scanners, microscopes, and
robotic automation. We are seeking scientists and post-doctoral fellows or Ph.D. students to join
two new cancer research programmes funded by the European Commission under the Marie Curie
Excellence Center Calls.
The Canceromics Programme, coordinated by Prof. Olli Kallioniemi, will start on 1st of August,
2004. We will focus on development and application of state-of-the-art biochip technologies
(CGH and NMD microarrays, array-based immunoprofiling of tumours and cell-based microarrays
for functional analysis) for identifying and validating therapeutic target genes for breast and
prostate cancer. We are looking for a Senior Scientist/Project Leader and a Post-Doctoral
Fellow or Ph.D. student.
The Kinetochore and Cancer Programme, coordinated by Dr Marko Kallio, will start on 1st of
August 2004. We will focus on the spindle checkpoint, a signalling pathway that regulates
integrity of cell division by monitoring microtubule-kinetochore interactions. Understanding
spindle checkpoint malfunction may help to explain how genetic instability arises and is expected
to identify novel therapeutic possibilities for treatment of cancer. We are looking for a PostDoctoral Fellow.
Qualifications: Senior scientist means Ph.D.-level researchers who have at the time of the
appointment more than 10 years (full-time equivalent) of research experience since obtaining
their Masters-level degree. Post-Doctoral fellow should have a doctoral degree and no more than
10 years of total research experience. The call is open for all nationalities.
Senior applicants should have a strong record of productivity and a background of research
excellence in molecular cell biology or high-throughput technologies. We are particularly
interested in candidates with expertise on microarrays, cellular signalling, live cell imaging, or
bioinformatics/systems biology, but we encourage applications from all candidates whose
expertise and interests complement and extend our ongoing activities.
Top candidates will be provided with a competitive salary and special benefits of the Marie Curie
programmes, such as international travel and living allowance with a family bonus. VTT
Biotechnology provides health care and other benefits. VTT operates an equal opportunities
policy. The official language of the research programmes is English.
Further information on the Institute and its current research portfolio can be found at
http://www.vtt.fi/bel/mbt. Please fill in your application at www.vtt.fi/vtt/jobs/ and paste your
CV in the space provided or email it to Tarja.Myllyntaus@vtt.fi by MAY 31, 2004. Please define
the specific programme and tasks that are of main interest to you.
Informal enquiries and applications can be addressed to: Olli.Kallioniemi@vtt.fi and
Marko.Kallio@vtt.fi. More information about the City of Turku can be found at
http://www.turku.fi/english/homepage/index.html.
VTT is a forerunner in technology with approximately 2800 employees. VTT provides a wide
range of technology and applied research services for its clients, private companies, institutions
and the public sector. VTT Biotechnology is one of the eight R&D disciplines of VTT. It has
approximately 300 employees and an annual turnover of 21 M€.
VTT BIOTECHNOLOGY
www.vtt.fi